Monthly Archives: November 2016

//November

Emotra’s application is given the “Seal of Excellence”

On November 28, Emotra announced that the Company’s Horizon 2020 application to the European Commission has been rejected. We have now had the opportunity to review the EC’s statement and we see that our application passed their threshold by a wide margin and that it was given a “Seal of Excellence”.   161130-emotra-nyhetsbrev-emotra-seal-of-excellence_en

By | November 30th, 2016|INVESTERARE|Comments Off on Emotra’s application is given the “Seal of Excellence”

Future report dates for Emotra

Emotra’s Board of Directors has decided the following dates for release of financial reports and the annual shareholder meeting   161128-emotra-nyhetsbrev-dates-for-financial-reports-en

By | November 28th, 2016|INVESTERARE|Comments Off on Future report dates for Emotra

European Commission Horizon 2020 – application rejected

The European Commission has rejected Emotra’s application for approximately 3 MEUR, which we intended to use for three purposes: First of all to finance EUDOR-Y, a clinical multi-centre study on young people, secondly to develop EDOR® Interconnect, and thirdly to further develop our hardware and software solutions. Emotra has not yet had the opportunity to [...]

By | November 28th, 2016|INVESTERARE|Comments Off on European Commission Horizon 2020 – application rejected

Emotra – Lars-Håkan Thorell held presentation in Chicago

Last week in Chicago, Lars-Håkan Thorell, the inventor of EDOR® and the Company’s Head of research, held a presentation that gathered a great deal of attention. He presented the result of his research and how it led to the development of EDOR®. 161031-emotra-news-letter-thorell-presented-in-chicago

By | November 2nd, 2016|INVESTERARE|Comments Off on Emotra – Lars-Håkan Thorell held presentation in Chicago